Muriel Lights  3 Piece  Candle Set

 Candle Set 2,4 and 9 ounce scented gel candle  

                                                                                 

                              

Muriel Lights Soy Melts

Candle Melts 2.6 weight, Scents available Coconut Creme Pie, Blueberry, Cinnamon Carrot Cake six cavity container.  Can be used in conventional candle burner or electric candle burner.  Soy melts have a longer burning time because they are made of vegetable oil (soy beans).  What's also great about soy melts is that they do not increase the CO2 level. soy  melts burn 50% longer which makes them more cost effective.  Soy melts burn cleaner, soy melts don't burn black soot.  Soy candle are non toxic because of the vegetable oil they are made from and they have a lower burning point.  One of soy melts greatest quality is the scent which is stronger and more pleasant than other candle wax.


Price $4.99 free shipping
Paypal: momdukes535@aol.com

Muriel Lights' Candle Designs: Diabetes Awareness This National Diabetes Month

Muriel Lights' Candle Designs: Diabetes Awareness This National Diabetes Month: Learn about diabetes and how it relates to your family hi...

Diabetes Awareness This National Diabetes Month

Learn about diabetes and how it relates to your family history. You can prevent or delay type 2 diabetes by learning your risk factors and making lifestyle changes with a group there in your community.

Diabetes: if you don't live with it yourself, then it's likely you have a family member or friend who does. This November during National Diabetes Month, ask yourself if you're at risk of type 2 diabetes and take steps to prevent it. Diabetes affects 26 million Americans, with 19 million people diagnosed and 7 million undiagnosed. And an estimated 79 million American adults aged 20 years or older have prediabetes, which puts them at high risk for developing the disease.

What is diabetes?

Diabetes is a disease in which blood glucose levels are above normal. Most of the food we eat is turned into glucose, or sugar, for our bodies to use for energy. The pancreas, an organ that lies near the stomach, makes a hormone called insulin to help glucose get into the cells of our bodies. When you have diabetes, your body either doesn't make enough insulin or can't use its own insulin as well as it should. This causes sugar to build up in your blood.

What are the types of diabetes? 

• Type 1 diabetes, which was previously called insulin-dependent diabetes mellitus or juvenile-onset diabetes, may account for about 5% of all diagnosed cases of diabetes.
• Type 2 diabetes, which was previously called non-insulin-dependent diabetes mellitus or adult-onset diabetes, may account for about 90% to 95% of all diagnosed cases of diabetes.
• Gestational diabetes is a type of diabetes that only pregnant women get. If not treated, it can cause problems for mothers and babies. Gestational diabetes develops in 2% to 10% of all pregnancies but usually disappears when a pregnancy is over.
• Other specific types of diabetes resulting from specific genetic syndromes, surgery, drugs, malnutrition, infections, and other illnesses may account for 1% to 5% of all diagnosed cases of diabetes.

Prediabetes is an elevated blood glucose level that is not quite high enough to be diagnosed as diabetes, but is higher than normal. One in three American adults has prediabetes, and most do not even know they have it. Many people with prediabetes who do not lose weight or do moderate physical activity will develop type 2 diabetes within 3 years.Diabetes can cause serious health complications including heart disease, blindness, kidney failure, and amputations of the foot, toe or leg. Diabetes is the seventh leading cause of death in the United States.

Risk Factors for Type 2 Diabetes

 
                                                                                                                                                                 You are at increased risk for developing prediabetes and type 2 diabetes if you:

• Are 45 years of age or older.
• Are overweight.
• Have a family history of type 2 diabetes.
• Are physically active fewer than three times per week.
• Ever gave birth to a baby that weighed more than 9 pounds.
• Ever had diabetes while pregnant (gestational diabetes).

What Can You Do?

Researchers are making progress in identifying the exact genetics and "triggers" that predispose some individuals to develop type 1 diabetes, but prevention remains elusive.
A number of studies have shown that regular physical activity can significantly reduce the risk of developing type 2 diabetes. Type 2 diabetes is associated with obesity.
The CDC-led National Diabetes Prevention Program is an evidence-based lifestyle change program for preventing type 2 diabetes.

• 
• It can help people cut their risk of developing type 2 diabetes in half.
• The Diabetes Prevention Program research study showed that making modest behavior changes helped participants lose 5% to 7% of their body weight—that is 10 to 14 pounds for a 200-pound person.
• These lifestyle changes reduced the risk of developing type 2 diabetes by 58% in people with prediabetes.
• Participants work with a lifestyle coach in a group setting to receive a 1-year lifestyle change program that includes 16 core sessions (usually 1 per week) and 6 post-core sessions (1 per month).

You don't have to do this alone. Prevent or delay type 2 diabetes today by learning about its risks and making lifestyle changes with a group in your community.

 Reference
National Center for Chronic Disease Prevention and Health Promotion, Division of Diabetes Translation
 Page last updated: October 31, 2013 Obtained November 13, 2013

Muriel Lights' Candle Designs: American Cancer Society Guidelines for the Early D...

Muriel Lights' Candle Designs: American Cancer Society Guidelines for the Early D...: The American Cancer Society recommends these screening guidelines for most adults. Breast cancer Yearly mammograms are recommended ...

Muriel Lights' Candle Designs: What is Compassionate Care?

Muriel Lights' Candle Designs: What is Compassionate Care?: As I was going through my e-mail I came across a petition for a cancer patient who had been denied experimental medication.  The patien...

What is Compassionate Care?

As I was going through my e-mail I came across a petition for a cancer patient who had been denied experimental medication.  The patient had tried every medication available and believed that the compassionate care medication available only from Drug Companies who is sponsoring drug trials was her husband only hope.   Medical professionals use the term “compassionate use” to refer to the treatment of a seriously ill patient using a new, unapproved drug when no other treatments are available in other words a cancer patient only hope.  Later that week on channel 2 news another person who had battled Uterus cancer for five years also had taken all available treatments.  Compassionate care medication was her last hope she also had a petition to help her get access to the trial medications available. Now the question for me was what is compassionate care and why was it so difficult for these cancer patients to get.

Compassionate Care                                                                                                                            Drugs that are being tested but have not yet been approved by the US Food and Drug Administration (FDA) are called investigational drugs. These drugs are generally available only to people who are taking part in a clinical trial (a research study that is testing the drug). Being able to use one of these drugs when you are not in a clinical trial has many names, but is most commonly referred to as compassionate use.  The FDA first approved investigational drugs to be use in this way for critically ill patients since 1987.  If you are not in a clinical trial there are 2 ways a drug company can allow use of their unapproved drug: through expanded access programs (EAP’s) or through single patient access.  Compassionate drug use is legal, but it’s tightly restricted to people who meet certain conditions. The FDA first approved investigational drugs to be used in this way for critically ill patients in 1987. For people who aren’t in clinical trials, there are 2 ways a drug company can allow use of their unapproved drug: through expanded access programs (EAPs) or through single patient access. 

Expanded access   
A company sponsoring a drug in the late stages of drug development, such as Phase III clinical trials, can offer expanded access programs for patients who are not able to enroll in a clinical.  The FDA generally approves these EAPs if the drug has shown that it works at least somewhat to treat cancer in the clinical trials that are being done. This can allow a lot of people access to the unapproved drug, as long as they meet the requirements of the EAP.

Single patient access    
Patients who don’t qualify for either clinical trials or an expanded access program (if one exists) may be able to get the unapproved new drug by applying for single patient access. In this case, the patient’s doctor must first ask the drug company if the drug can be used for the patient and see if the drug company will supply it. If the company agrees, the patient’s doctor works with the drug company to ask the FDA to approve the drug for use by this one patient.

The FDA requires the doctor to send information about the patient, why the request is being made, the proposed treatment plan, and a signed informed consent from the patient (see our document Informed Consent for more on this). The length of time it takes to get single patient access varies. But if it’s an emergency, the FDA can complete the paperwork in 24 hours.

Who might benefit from using unapproved drugs?      
According to guidelines from the National Cancer Institute, most compassionate drug use is for patients who meet all of these conditions:

• Have advanced disease
• Have used standard treatments and they have not worked
• Are not eligible for any clinical trial that’s in progress
• Have no other treatment options
• Have a type of cancer for which there’s reason to expect the investigational drug will help
• Are likely to have benefits that outweigh the risks involved

In a case like this, the doctor may consider trying to get a new, unapproved drug for a patient to see if it will help.

Is it difficult to get drugs for compassionate use?   
Perhaps the biggest problem with compassionate drug use is that it’s hard to get the drug. The simplest way to get an unapproved drug is through a clinical trial. But many people with life-threatening diseases can’t find suitable clinical trials, live far from cancer research centers, or are not eligible for any studies being done.

What I have seen from the patients fighting to get compassionate use they have to do a lot of advocating far beyond the process in place in a time when fighting their cancer should be their only worry. Getting the drug through expanded access programs (if one is offered by the drug company) or single-patient compassionate use is possible for some people. But going through all the steps needed to get single-patient compassionate use of an unapproved drug can be frustrating and take a lot of time. For instance, drug companies have different policies and processes. And there’s no way to force the drug company to supply the drug. There may be very limited amounts of the drug, and producing extra medicine for people who are not in clinical trials can be costly for the drug company, especially when there’s a chance the drug might never be approved.

Compassionate drug use can also be very confusing. There are several programs that regulate it. Many terms and definitions are used to describe how a patient may get access to an unapproved drug outside of a clinical trial. Drug companies, patient advocacy groups, and the FDA all may use different terms for the same things. The FDA provides definitions for the terms they use in their regulations. But most drug companies use different terms that are unique to their specific compassionate access programs.

Another big problem is cost. Some drug companies will supply the drug for free, but others charge patients. Most insurance companies will not pay for investigational drugs. There may also be other costs, such as the clinic’s cost of giving the drug and monitoring your response, which might not be covered by your health insurance. 

How common is compassionate drug use?
Before a patient or group of patients can get an unapproved new cancer drug outside of a clinical trial, 2 things MUST happen:

• The owner (sometimes referred to as the sponsor – most often a drug company) of the new, unapproved drug must agree to allow the use of their drug outside of a clinical trial.
• The FDA oncology medical officer in charge of overseeing the new drug’s development must approve the use of the drug for that person or group.

What should I ask my doctor about compassionate drug use?                                                        Here are some questions you may want to ask if your doctor is thinking about compassionate drug use at this point in your cancer treatment.

• Are there any approved treatments that I haven’t tried?
• Is there any evidence to support the use of this drug to treat my type of cancer?
• What makes you think this drug could help me?
• In what way do you think this drug is likely to work better than an approved drug?
• What are the known risks and benefits of treatment with this drug?
• Will the drug company give me the drug for free? If not, how is it to be paid for? What other costs will I have to pay to get the drug? Will my insurance cover any costs?
• What will I have to do to get access to this drug?
• How long do you think it will take for me to get access to this drug?

                                                                                                                                                                                

                                                               References

www.canceractionnow.org/living/cat_compassionate_use_and_expanded_access.phpcompassionate.php on September 15, 2013

http://www.cancer.org/treatment/treatmentsandsideeffects/clinicaltrials/compassionate-drug-use                  on September 15, 2013